| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 25 | 2024 | 483 | 4.740 |
Why?
|
| Muscular Dystrophy, Duchenne | 10 | 2024 | 39 | 2.800 |
Why?
|
| Annexin A6 | 6 | 2022 | 10 | 2.050 |
Why?
|
| Muscular Dystrophies | 7 | 2024 | 55 | 1.940 |
Why?
|
| Muscle Proteins | 8 | 2021 | 134 | 1.930 |
Why?
|
| Cell Membrane | 9 | 2021 | 696 | 1.830 |
Why?
|
| Membrane Proteins | 11 | 2021 | 1276 | 1.790 |
Why?
|
| Muscular Dystrophy, Animal | 8 | 2019 | 21 | 1.690 |
Why?
|
| Muscle Fibers, Skeletal | 6 | 2019 | 54 | 1.630 |
Why?
|
| Immunoglobulin G | 6 | 2023 | 481 | 1.600 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 6 | 2024 | 15 | 1.340 |
Why?
|
| Dysferlin | 6 | 2024 | 14 | 1.260 |
Why?
|
| Calcium | 4 | 2022 | 1205 | 1.090 |
Why?
|
| Mice, Inbred mdx | 5 | 2024 | 16 | 1.070 |
Why?
|
| Muscle Development | 6 | 2019 | 45 | 1.040 |
Why?
|
| Dried Blood Spot Testing | 3 | 2021 | 10 | 1.020 |
Why?
|
| Vesicular Transport Proteins | 3 | 2015 | 70 | 0.950 |
Why?
|
| Muscles | 3 | 2024 | 193 | 0.910 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 2551 | 0.890 |
Why?
|
| Vaccines, Synthetic | 2 | 2021 | 60 | 0.880 |
Why?
|
| Mice | 28 | 2025 | 12562 | 0.810 |
Why?
|
| Myoblasts | 7 | 2024 | 33 | 0.760 |
Why?
|
| Sarcolemma | 10 | 2019 | 32 | 0.750 |
Why?
|
| Animals | 37 | 2025 | 28945 | 0.750 |
Why?
|
| Sarcoglycans | 7 | 2024 | 14 | 0.750 |
Why?
|
| Membrane Fusion | 3 | 2021 | 38 | 0.730 |
Why?
|
| Myocytes, Cardiac | 8 | 2024 | 324 | 0.720 |
Why?
|
| Neuromuscular Diseases | 1 | 2021 | 30 | 0.720 |
Why?
|
| Excitation Contraction Coupling | 1 | 2021 | 8 | 0.710 |
Why?
|
| Biomarkers | 3 | 2024 | 1933 | 0.700 |
Why?
|
| Family Characteristics | 2 | 2022 | 52 | 0.700 |
Why?
|
| Serologic Tests | 2 | 2021 | 43 | 0.700 |
Why?
|
| Annexins | 2 | 2022 | 6 | 0.690 |
Why?
|
| Pandemics | 5 | 2023 | 880 | 0.640 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2024 | 139 | 0.640 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2010 | 116 | 0.620 |
Why?
|
| Exons | 3 | 2019 | 454 | 0.610 |
Why?
|
| Gene Editing | 1 | 2019 | 52 | 0.610 |
Why?
|
| Spike Glycoprotein, Coronavirus | 5 | 2022 | 59 | 0.600 |
Why?
|
| Antibodies, Viral | 6 | 2022 | 348 | 0.560 |
Why?
|
| Health Personnel | 1 | 2020 | 241 | 0.560 |
Why?
|
| Muscle Cells | 1 | 2017 | 18 | 0.530 |
Why?
|
| Betacoronavirus | 1 | 2020 | 284 | 0.520 |
Why?
|
| Prednisone | 4 | 2024 | 258 | 0.520 |
Why?
|
| Protein Transport | 8 | 2016 | 439 | 0.510 |
Why?
|
| Health | 1 | 2015 | 29 | 0.470 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 346 | 0.460 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 334 | 0.460 |
Why?
|
| Disease | 1 | 2015 | 92 | 0.450 |
Why?
|
| Neutralization Tests | 4 | 2022 | 77 | 0.450 |
Why?
|
| Glucocorticoids | 5 | 2024 | 369 | 0.440 |
Why?
|
| Muscular Diseases | 3 | 2023 | 68 | 0.430 |
Why?
|
| Dynamin II | 1 | 2014 | 15 | 0.430 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2014 | 11 | 0.420 |
Why?
|
| Proteostasis | 2 | 2024 | 12 | 0.420 |
Why?
|
| Quadriceps Muscle | 1 | 2014 | 8 | 0.420 |
Why?
|
| Glycerol | 1 | 2013 | 37 | 0.410 |
Why?
|
| Male | 20 | 2025 | 45870 | 0.400 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3651 | 0.400 |
Why?
|
| Actins | 1 | 2016 | 473 | 0.390 |
Why?
|
| Fibrosis | 4 | 2023 | 246 | 0.370 |
Why?
|
| Mice, Knockout | 6 | 2024 | 2163 | 0.370 |
Why?
|
| Antibodies, Neutralizing | 3 | 2022 | 163 | 0.370 |
Why?
|
| Gene Expression | 3 | 2019 | 1322 | 0.360 |
Why?
|
| Antibody Formation | 2 | 2021 | 181 | 0.340 |
Why?
|
| Seroepidemiologic Studies | 2 | 2021 | 57 | 0.340 |
Why?
|
| RNA, Messenger | 3 | 2019 | 2092 | 0.330 |
Why?
|
| Mice, 129 Strain | 3 | 2021 | 58 | 0.330 |
Why?
|
| NFATC Transcription Factors | 1 | 2010 | 50 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 7 | 2025 | 3490 | 0.320 |
Why?
|
| Latent TGF-beta Binding Proteins | 2 | 2021 | 4 | 0.320 |
Why?
|
| DNA | 1 | 2015 | 1332 | 0.320 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2009 | 45 | 0.320 |
Why?
|
| Wound Healing | 4 | 2016 | 378 | 0.310 |
Why?
|
| Female | 16 | 2025 | 50063 | 0.300 |
Why?
|
| Humans | 29 | 2024 | 96127 | 0.280 |
Why?
|
| Extracellular Matrix | 3 | 2024 | 259 | 0.280 |
Why?
|
| Carrier Proteins | 3 | 2021 | 684 | 0.260 |
Why?
|
| Young Adult | 5 | 2024 | 7025 | 0.260 |
Why?
|
| Vaccination | 3 | 2023 | 311 | 0.230 |
Why?
|
| Myosin Type V | 1 | 2025 | 13 | 0.230 |
Why?
|
| Cells, Cultured | 6 | 2018 | 2943 | 0.230 |
Why?
|
| Regeneration | 3 | 2017 | 161 | 0.220 |
Why?
|
| Ataxia | 1 | 2025 | 47 | 0.220 |
Why?
|
| Myosin Heavy Chains | 1 | 2025 | 91 | 0.220 |
Why?
|
| Immunoblotting | 2 | 2016 | 280 | 0.220 |
Why?
|
| Filamins | 1 | 2024 | 22 | 0.220 |
Why?
|
| Middle Aged | 7 | 2024 | 28363 | 0.210 |
Why?
|
| Adult | 7 | 2024 | 28718 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2024 | 45 | 0.210 |
Why?
|
| Cardiomyopathies | 2 | 2024 | 289 | 0.210 |
Why?
|
| Myocarditis | 1 | 2024 | 58 | 0.200 |
Why?
|
| Mice, Inbred DBA | 6 | 2024 | 149 | 0.200 |
Why?
|
| Mice, Mutant Strains | 2 | 2016 | 232 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 307 | 0.190 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2015 | 301 | 0.190 |
Why?
|
| Tissue Engineering | 1 | 2024 | 202 | 0.190 |
Why?
|
| Mice, Transgenic | 4 | 2022 | 1645 | 0.190 |
Why?
|
| Calcium-Binding Proteins | 2 | 2021 | 120 | 0.190 |
Why?
|
| Immunologic Tests | 1 | 2021 | 6 | 0.180 |
Why?
|
| Monocytes | 1 | 2023 | 231 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 515 | 0.180 |
Why?
|
| Drug Interactions | 1 | 2021 | 245 | 0.170 |
Why?
|
| Extracellular Vesicles | 1 | 2022 | 47 | 0.170 |
Why?
|
| Mitochondria | 1 | 2025 | 623 | 0.170 |
Why?
|
| Heart Diseases | 1 | 2023 | 314 | 0.170 |
Why?
|
| Steroids | 1 | 2021 | 174 | 0.170 |
Why?
|
| Genes, Modifier | 2 | 2017 | 5 | 0.160 |
Why?
|
| Cell Differentiation | 2 | 2024 | 1666 | 0.160 |
Why?
|
| Immunity, Innate | 1 | 2024 | 464 | 0.160 |
Why?
|
| Muscle Contraction | 1 | 2021 | 294 | 0.160 |
Why?
|
| Cell Movement | 1 | 2024 | 820 | 0.160 |
Why?
|
| Chicago | 2 | 2021 | 1503 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 380 | 0.150 |
Why?
|
| Lysosomes | 2 | 2010 | 124 | 0.150 |
Why?
|
| Myotonic Dystrophy | 1 | 2019 | 7 | 0.150 |
Why?
|
| MyoD Protein | 1 | 2019 | 16 | 0.150 |
Why?
|
| Dual Specificity Phosphatase 6 | 1 | 2019 | 1 | 0.150 |
Why?
|
| Mutation | 4 | 2025 | 4374 | 0.150 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 349 | 0.150 |
Why?
|
| Point Mutation | 1 | 2019 | 247 | 0.150 |
Why?
|
| Signal Transduction | 1 | 2009 | 3586 | 0.150 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 1981 | 0.140 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 124 | 0.140 |
Why?
|
| Sarcoglycanopathies | 1 | 2018 | 2 | 0.140 |
Why?
|
| Morpholinos | 1 | 2018 | 13 | 0.140 |
Why?
|
| Dystrophin | 4 | 2024 | 25 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2024 | 1323 | 0.140 |
Why?
|
| Adolescent | 2 | 2021 | 9896 | 0.140 |
Why?
|
| Phenotype | 1 | 2024 | 2579 | 0.140 |
Why?
|
| Osteopontin | 1 | 2017 | 48 | 0.130 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 1034 | 0.130 |
Why?
|
| Protein Binding | 4 | 2022 | 1561 | 0.130 |
Why?
|
| Genetic Therapy | 2 | 2018 | 382 | 0.130 |
Why?
|
| Phospholipids | 1 | 2017 | 113 | 0.130 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 2040 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 2 | 2018 | 444 | 0.120 |
Why?
|
| Exosomes | 1 | 2017 | 60 | 0.120 |
Why?
|
| Cell Communication | 1 | 2017 | 221 | 0.120 |
Why?
|
| Dystrophin-Associated Protein Complex | 1 | 2015 | 3 | 0.120 |
Why?
|
| Base Sequence | 1 | 2019 | 2344 | 0.120 |
Why?
|
| Electroporation | 1 | 2015 | 57 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2024 | 1730 | 0.120 |
Why?
|
| Creatine Kinase | 1 | 2015 | 53 | 0.120 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2015 | 67 | 0.120 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 145 | 0.110 |
Why?
|
| Plasmids | 1 | 2015 | 291 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 286 | 0.110 |
Why?
|
| Intracellular Space | 2 | 2014 | 38 | 0.110 |
Why?
|
| Heterozygote | 1 | 2015 | 382 | 0.110 |
Why?
|
| Protein Engineering | 1 | 2015 | 150 | 0.110 |
Why?
|
| Cell Line | 4 | 2024 | 2533 | 0.110 |
Why?
|
| Cell Adhesion | 1 | 2015 | 444 | 0.110 |
Why?
|
| Caveolin 3 | 1 | 2014 | 4 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 2473 | 0.110 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 262 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2021 | 3107 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 930 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 138 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 396 | 0.100 |
Why?
|
| HIV Infections | 1 | 2023 | 974 | 0.100 |
Why?
|
| Cell Survival | 1 | 2015 | 1032 | 0.100 |
Why?
|
| Aged | 2 | 2021 | 20964 | 0.100 |
Why?
|
| Endosomes | 2 | 2010 | 86 | 0.100 |
Why?
|
| Cytoskeleton | 1 | 2014 | 200 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2017 | 592 | 0.090 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2010 | 6 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 2059 | 0.080 |
Why?
|
| Cardiotoxins | 1 | 2010 | 3 | 0.080 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2009 | 4 | 0.080 |
Why?
|
| Myoblasts, Skeletal | 1 | 2009 | 4 | 0.080 |
Why?
|
| Myofibrils | 1 | 2009 | 22 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2010 | 142 | 0.080 |
Why?
|
| Models, Animal | 1 | 2010 | 288 | 0.070 |
Why?
|
| Models, Biological | 1 | 2015 | 1815 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2494 | 0.070 |
Why?
|
| Endocytosis | 1 | 2008 | 186 | 0.070 |
Why?
|
| RNA Splicing | 2 | 2019 | 159 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 992 | 0.060 |
Why?
|
| Lamin Type A | 1 | 2006 | 26 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2022 | 706 | 0.060 |
Why?
|
| Annexin A2 | 1 | 2024 | 2 | 0.050 |
Why?
|
| Decorin | 1 | 2024 | 6 | 0.050 |
Why?
|
| Electrophysiological Phenomena | 1 | 2024 | 52 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2006 | 623 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2024 | 151 | 0.050 |
Why?
|
| Bortezomib | 1 | 2024 | 82 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2024 | 141 | 0.050 |
Why?
|
| Immunization, Secondary | 1 | 2023 | 38 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2024 | 206 | 0.050 |
Why?
|
| Quantitative Trait Loci | 2 | 2019 | 632 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 750 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 51 | 0.050 |
Why?
|
| Vero Cells | 1 | 2022 | 106 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2024 | 252 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2024 | 938 | 0.040 |
Why?
|
| Antibodies, Blocking | 1 | 2021 | 22 | 0.040 |
Why?
|
| Proteomics | 1 | 2023 | 269 | 0.040 |
Why?
|
| Heart | 1 | 2024 | 592 | 0.040 |
Why?
|
| Immunoassay | 1 | 2021 | 100 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2022 | 521 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 750 | 0.040 |
Why?
|
| Anacardic Acids | 1 | 2019 | 1 | 0.040 |
Why?
|
| Pulse Therapy, Drug | 1 | 2019 | 2 | 0.040 |
Why?
|
| MEF2 Transcription Factors | 1 | 2019 | 10 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 350 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2019 | 1423 | 0.040 |
Why?
|
| Histone Acetyltransferases | 1 | 2019 | 45 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2021 | 213 | 0.040 |
Why?
|
| Metabolomics | 1 | 2019 | 98 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2019 | 109 | 0.040 |
Why?
|
| Epigenomics | 1 | 2019 | 107 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 1568 | 0.040 |
Why?
|
| Reading Frames | 1 | 2018 | 6 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2022 | 1546 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 84 | 0.030 |
Why?
|
| Annexin A1 | 1 | 2017 | 5 | 0.030 |
Why?
|
| Cellular Reprogramming | 1 | 2018 | 51 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2018 | 162 | 0.030 |
Why?
|
| Urine | 1 | 2018 | 96 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 813 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 52 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2019 | 302 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 111 | 0.030 |
Why?
|
| Muscular Atrophy | 1 | 2017 | 48 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 305 | 0.030 |
Why?
|
| Neurons | 1 | 2025 | 1653 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 303 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 1083 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2017 | 144 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 348 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 47 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 873 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 81 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 554 | 0.030 |
Why?
|
| Diaphragm | 1 | 2015 | 75 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2883 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 781 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2015 | 213 | 0.030 |
Why?
|
| Membranes | 1 | 2014 | 37 | 0.030 |
Why?
|
| Abdominal Muscles | 1 | 2014 | 23 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2014 | 38 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 1874 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 564 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 379 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 220 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2014 | 220 | 0.020 |
Why?
|
| Time Factors | 1 | 2021 | 5585 | 0.020 |
Why?
|
| Myocardium | 1 | 2015 | 596 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 523 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 633 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 567 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2014 | 810 | 0.020 |
Why?
|
| Transferrin | 1 | 2008 | 21 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2008 | 39 | 0.020 |
Why?
|
| Child | 1 | 2019 | 7626 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2008 | 215 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2008 | 360 | 0.020 |
Why?
|
| Nuclear Envelope | 1 | 2006 | 39 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2006 | 99 | 0.020 |
Why?
|
| Hydroxyproline | 1 | 2005 | 11 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 2092 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2008 | 1375 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 3041 | 0.010 |
Why?
|
| Motor Activity | 1 | 2005 | 331 | 0.010 |
Why?
|